Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

163
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
163
Depression: Overview01:18

Depression: Overview

330
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
330
Long-term Depression01:05

Long-term Depression

31.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.4K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

207
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
207
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

326
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
326
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

121.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deacetyl xylopic acid exhibits synergistic antidepressant-like effects and augments fluoxetine activity in a chronic restraint-induced depression model in mice.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Medication error reporting in Ghana: A multicenter assessment of healthcare professionals' knowledge, attitudes and practices.

PloS one·2026
Same author

Towards Mechanism-Informed Treatments for Mental Health.

Journal of neurochemistry·2026
Same author

Medication errors and medication error reporting practices in Ghana: a systematic review.

Therapeutic advances in drug safety·2026
Same author

Pain Experience and Patient-Reported Barriers to Analgesic Use in Emergency Care in Ghana: A Cross-Sectional Study.

Health science reports·2026
Same author

Comprehensive sub-chronic toxicological profiling of illegal artisanal small-scale mining-polluted river bodies in four regions of Ghana.

Toxicology reports·2026

Related Experiment Video

Updated: Sep 6, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K

Depression in Sub-Saharan Africa.

Ismail Temitayo Gbadamosi1,2, Isaac Tabiri Henneh3, Oritoke Modupe Aluko4

  • 1Department of Anatomy, University of Ilorin, Nigeria.

IBRO Neuroscience Reports
|June 24, 2022
PubMed
Summary

Depression significantly impacts quality of life globally. This review explores depression prevalence, pathophysiology, and management challenges specifically within Sub-Saharan Africa.

Keywords:
AntidepressantsMajor depressive disorderMedicinal plantsSub-Saharan Africa

More Related Videos

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.1K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

170

Related Experiment Videos

Last Updated: Sep 6, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.1K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

170

Area of Science:

  • Neuroscience
  • Psychiatry
  • Global Health

Background:

  • Mood disorders, particularly major depression, are highly debilitating and reduce quality of life.
  • Depression is projected to be the leading cause of mental illness globally by 2030.
  • There is limited research contextualizing depression in Africa.

Purpose of the Study:

  • To review the prevalence, pathophysiology, risk factors, and diagnostic approaches to depression in Sub-Saharan Africa (SSA).
  • To examine available experimental models for studying depression in SSA.
  • To evaluate SSA's contribution to global depression research and identify management bottlenecks.

Main Methods:

  • Literature review focusing on depression in Sub-Saharan Africa.
  • Analysis of prevalence data, risk factors, and diagnostic challenges.
  • Assessment of research output and resource utilization for depression management.

Main Results:

  • The review synthesizes current knowledge on depression in SSA.
  • Identifies gaps in understanding pathophysiology and risk factors specific to the region.
  • Highlights challenges in research and resource exploitation for effective management.

Conclusions:

  • Further research is needed to understand and manage depression effectively in Sub-Saharan Africa.
  • Context-specific strategies are crucial for addressing the growing burden of depression in the region.
  • Overcoming research and resource bottlenecks is essential for improving mental health outcomes in SSA.